TPCW
TVRD

TD Private Client Wealth’s Tvardi Therapeutics TVRD Stock Holding History

TD Private Client Wealth’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283 Buy
+149
New +$467 ﹤0.01% 1619

Other funds holding TVRD

DWAM
Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

TD Private Client Wealth's TVRD Position: Q2 2026 in Review

TD Private Client Wealth opened a new position in Tvardi Therapeutics (TVRD) in Q2 2026: 149 shares worth $283. The stake represents ﹤0.01% of the portfolio and ranks #1619 among its holdings.

15 funds tracked by Wall St. Rank hold TVRD as of Q2 2026.

  • TD Private Client Wealth held 149 shares of Tvardi Therapeutics worth $283 as of Q2 2026.
  • Tvardi Therapeutics was a new TD Private Client Wealth position in Q2 2026.
  • Tvardi Therapeutics made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1619 holding.
  • 15 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.